China's manufacturing activity contracted sharply in December for the third month in a row, according to Purchasing Managers' Index (PMI)
The coutry’s PMI came in at 47 points, down from November's 48 and well below the 50-point mark separating growth from contraction, despite China loosening COVID restrictions at the beginning of the month.
For over two years, China had imposed a zero-COVID strategy with strict quarantines, lockdowns, and mass testing that led to unannounced plant closures, disrupted supply chains, and forced permanent company closures.
China abruptly loosened pandemic restrictions on December 7, but the country is still struggling to recover due to a surge in COVID cases.
NBS senior statistician Zhao Qinghe noted that the pandemic has had a significant impact on business production and demand, staff presence, logistics, and distribution.
The index has not been in positive territory since September, and December's figure was lower than the 47.8 reading predicted by Bloomberg analysts.
For its part, the non-manufacturing PMI -- which includes the services and construction sectors -- also contracted further this month, to 41.6 points from 46.7 in November.


Pfizer Boosts Bid for Metsera Amid Intensifying Rivalry with Novo Nordisk in Obesity Drug Market
EU Prepares Antitrust Probe Into Meta’s AI Integration on WhatsApp
YouTube Agrees to Follow Australia’s New Under-16 Social Media Ban
Trump Administration to Launch Autism Initiatives Targeting Acetaminophen Use and New Treatment Options
BOJ Faces Pressure for Clarity, but Neutral Rate Estimates Likely to Stay Vague
Germany’s Economic Recovery Slows as Trade Tensions and Rising Costs Weigh on Growth
Asian Currencies Edge Higher as Markets Look to Fed Rate Cut; Rupee Steadies Near Record Lows
Merck Nears Acquisition of Cidara Therapeutics at Significant Premium
IKEA Expands U.S. Manufacturing Amid Rising Tariffs and Supply Chain Strategy Shift
Airbus Faces Pressure After November Deliveries Dip Amid Industrial Setback
OpenAI Moves to Acquire Neptune as It Expands AI Training Capabilities
Proxy Advisors Urge Vote Against ANZ’s Executive Pay Report Amid Scandal Fallout
Obamacare Premiums Set to Double in 2026 as Subsidy Expiration Looms Amid U.S. Shutdown
CDC Shake-Up Sparks Vaccine Policy Clash Between RFK Jr. and Susan Monarez
Amazon Italy Pays €180M in Compensation as Delivery Staff Probe Ends
Oil Prices Hold Steady as Ukraine Tensions and Fed Cut Expectations Support Market
Novartis to Acquire Avidity Biosciences for $12 Billion to Strengthen Rare Muscle Disorder Portfolio 



